Similar findings were reported by Wiegand et al. [33], who noted that PIK3CA and ARID1A are more frequently mutated in clear cell and endometrioid ovarian cancers, which are subtypes that generally lack CCNE1 amplification. Here, ARID1A is linked to ovarian endometrioid adenocarcinoma.